ロード中...
Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
Chronic Myeloid Leukaemia is a myeloproliferative disorder driven by the t(9;22) chromosomal translocation coding for the chimeric protein BCR-ABL. CML treatment represents the paradigm of molecular therapy of cancer. Since the development of the tyrosine kinase inhibitor of the BCR-ABL kinase, the...
保存先:
| 出版年: | Blood Lymphat Cancer |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842740/ https://ncbi.nlm.nih.gov/pubmed/31807112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S228815 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|